Cite
Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages.
MLA
Chai, Jianshen, et al. “Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages.” PLoS ONE, vol. 11, no. 9, Sept. 2016, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0163634.
APA
Chai, J., Luo, L., Hou, F., Fan, X., Yu, J., Ma, W., Tang, W., Yang, X., Zhu, J., Kang, W., Yan, J., & Liang, H. (2016). Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages. PLoS ONE, 11(9), 1–16. https://doi.org/10.1371/journal.pone.0163634
Chicago
Chai, Jianshen, Li Luo, Fengyan Hou, Xia Fan, Jing Yu, Wei Ma, Wangqi Tang, et al. 2016. “Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages.” PLoS ONE 11 (9): 1–16. doi:10.1371/journal.pone.0163634.